{
  "company_number": "04352134",
  "name": "Jules Pharma Limited",
  "url": "/company/04352134",
  "status": "Active",
  "is_active": true,
  "company_type": "Private Limited Company",
  "incorporated_on": "2002-01-14",
  "dissolved_on": null,
  "sic_codes": [
    {
      "code": "46460",
      "description": "Wholesale of pharmaceutical goods",
      "section": "G",
      "section_name": "Wholesale and retail trade; repair of motor vehicles and motorcycles",
      "url": "/sic/46460"
    }
  ],
  "registered_address": {
    "id": 1652439,
    "url": "/address/1652439",
    "line1": "10 LYNDHURST ROAD",
    "line2": "COULSDON",
    "post_town": "SURREY",
    "county": "",
    "country": "",
    "postcode": "CR5 3HT"
  },
  "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/04352134",
  "previous_names": [],
  "care_of": "",
  "po_box": "",
  "country_of_origin": "United Kingdom",
  "accounts": {
    "next_due": "2027-10-31",
    "last_made_up": "2026-01-31",
    "category": "MICRO ENTITY",
    "filings": [
      {
        "url": "/company/04352134/accounts/2026-01-31",
        "pdf_url": "/company/04352134/accounts/2026-01-31.pdf",
        "made_up_date": "2026-01-31",
        "period_start": "2026-01-31",
        "period_end": "2026-01-31",
        "entity_name": "Jules Pharma Limited",
        "dormant": false,
        "average_employees": "1.00",
        "tangible_fixed_assets": "18.00",
        "debtors": null,
        "cash_bank_in_hand": null,
        "current_assets": "22625.00",
        "creditors_due_within_one_year": "13109.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "9516.00",
        "total_assets_less_current_liabilities": "9534.00",
        "net_assets_liabilities": null,
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "8934.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-June2026.zip"
      },
      {
        "url": "/company/04352134/accounts/2025-01-31",
        "pdf_url": "/company/04352134/accounts/2025-01-31.pdf",
        "made_up_date": "2025-01-31",
        "period_start": "2025-01-31",
        "period_end": "2025-01-31",
        "entity_name": "Jules Pharma Limited",
        "dormant": false,
        "average_employees": "1.00",
        "tangible_fixed_assets": "25.00",
        "debtors": null,
        "cash_bank_in_hand": null,
        "current_assets": "23053.00",
        "creditors_due_within_one_year": "23979.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-926.00",
        "total_assets_less_current_liabilities": "-901.00",
        "net_assets_liabilities": null,
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "-1501.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-October2025.zip"
      },
      {
        "url": "/company/04352134/accounts/2024-01-31",
        "pdf_url": "/company/04352134/accounts/2024-01-31.pdf",
        "made_up_date": "2024-01-31",
        "period_start": "2024-01-31",
        "period_end": "2024-01-31",
        "entity_name": "Jules Pharma Limited",
        "dormant": false,
        "average_employees": "1.00",
        "tangible_fixed_assets": "33.00",
        "debtors": null,
        "cash_bank_in_hand": null,
        "current_assets": "21037.00",
        "creditors_due_within_one_year": "30216.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-9179.00",
        "total_assets_less_current_liabilities": "-9146.00",
        "net_assets_liabilities": null,
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "-9746.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-September2024.zip"
      },
      {
        "url": "/company/04352134/accounts/2023-01-31",
        "pdf_url": "/company/04352134/accounts/2023-01-31.pdf",
        "made_up_date": "2023-01-31",
        "period_start": "2023-01-31",
        "period_end": "2023-01-31",
        "entity_name": "Jules Pharma Limited",
        "dormant": false,
        "average_employees": "1.00",
        "tangible_fixed_assets": "44.00",
        "debtors": null,
        "cash_bank_in_hand": null,
        "current_assets": "37859.00",
        "creditors_due_within_one_year": "30218.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "7641.00",
        "total_assets_less_current_liabilities": "7685.00",
        "net_assets_liabilities": null,
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "7085.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-October2023.zip"
      },
      {
        "url": "/company/04352134/accounts/2022-01-31",
        "pdf_url": "/company/04352134/accounts/2022-01-31.pdf",
        "made_up_date": "2022-01-31",
        "period_start": "2022-01-31",
        "period_end": "2022-01-31",
        "entity_name": "Jules Pharma Limited",
        "dormant": false,
        "average_employees": "1.00",
        "tangible_fixed_assets": "59.00",
        "debtors": null,
        "cash_bank_in_hand": "19962.00",
        "current_assets": null,
        "creditors_due_within_one_year": "24897.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-4935.00",
        "total_assets_less_current_liabilities": "-4876.00",
        "net_assets_liabilities": "-4876.00",
        "called_up_share_capital": "1.00",
        "profit_loss_account_reserve": "-4877.00",
        "shareholder_funds": "1.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-October2022.zip"
      },
      {
        "url": "/company/04352134/accounts/2021-01-31",
        "pdf_url": "/company/04352134/accounts/2021-01-31.pdf",
        "made_up_date": "2021-01-31",
        "period_start": "2021-01-31",
        "period_end": "2021-01-31",
        "entity_name": "Jules Pharma Limited",
        "dormant": false,
        "average_employees": "1.00",
        "tangible_fixed_assets": "78.00",
        "debtors": null,
        "cash_bank_in_hand": "587.00",
        "current_assets": null,
        "creditors_due_within_one_year": "20895.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-20308.00",
        "total_assets_less_current_liabilities": "-20230.00",
        "net_assets_liabilities": "-20230.00",
        "called_up_share_capital": "1.00",
        "profit_loss_account_reserve": "-20231.00",
        "shareholder_funds": "1.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-October2021.zip"
      },
      {
        "url": "/company/04352134/accounts/2020-01-31",
        "pdf_url": "/company/04352134/accounts/2020-01-31.pdf",
        "made_up_date": "2020-01-31",
        "period_start": "2020-01-31",
        "period_end": "2020-01-31",
        "entity_name": "Jules Pharma Limited",
        "dormant": false,
        "average_employees": "1.00",
        "tangible_fixed_assets": "105.00",
        "debtors": null,
        "cash_bank_in_hand": "564.00",
        "current_assets": "564.00",
        "creditors_due_within_one_year": "11783.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-11219.00",
        "total_assets_less_current_liabilities": "-11114.00",
        "net_assets_liabilities": "-11114.00",
        "called_up_share_capital": "1.00",
        "profit_loss_account_reserve": "-11115.00",
        "shareholder_funds": "1.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-November2020.zip"
      },
      {
        "url": "/company/04352134/accounts/2019-01-31",
        "pdf_url": "/company/04352134/accounts/2019-01-31.pdf",
        "made_up_date": "2019-01-31",
        "period_start": "2019-01-31",
        "period_end": "2019-01-31",
        "entity_name": "Jules Pharma Limited",
        "dormant": false,
        "average_employees": "1.00",
        "tangible_fixed_assets": "139.00",
        "debtors": "4788.00",
        "cash_bank_in_hand": null,
        "current_assets": "4788.00",
        "creditors_due_within_one_year": "3265.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "1523.00",
        "total_assets_less_current_liabilities": "1662.00",
        "net_assets_liabilities": "1662.00",
        "called_up_share_capital": "1.00",
        "profit_loss_account_reserve": "1661.00",
        "shareholder_funds": "1.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-October2019.zip"
      },
      {
        "url": "/company/04352134/accounts/2018-01-31",
        "pdf_url": "/company/04352134/accounts/2018-01-31.pdf",
        "made_up_date": "2018-01-31",
        "period_start": "2018-01-31",
        "period_end": "2018-01-31",
        "entity_name": "Jules Pharma Limited",
        "dormant": false,
        "average_employees": "1.00",
        "tangible_fixed_assets": "186.00",
        "debtors": "8570.00",
        "cash_bank_in_hand": "4931.00",
        "current_assets": "13501.00",
        "creditors_due_within_one_year": "2476.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "11025.00",
        "total_assets_less_current_liabilities": "11211.00",
        "net_assets_liabilities": "11211.00",
        "called_up_share_capital": "1.00",
        "profit_loss_account_reserve": "11210.00",
        "shareholder_funds": "1.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-October2018.zip"
      },
      {
        "url": "/company/04352134/accounts/2017-01-31",
        "pdf_url": "/company/04352134/accounts/2017-01-31.pdf",
        "made_up_date": "2017-01-31",
        "period_start": "2017-01-31",
        "period_end": "2017-01-31",
        "entity_name": "Jules Pharma Limited",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "248.00",
        "debtors": "4429.00",
        "cash_bank_in_hand": "2302.00",
        "current_assets": "6731.00",
        "creditors_due_within_one_year": "1598.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "5133.00",
        "total_assets_less_current_liabilities": "5381.00",
        "net_assets_liabilities": "5381.00",
        "called_up_share_capital": "1.00",
        "profit_loss_account_reserve": "5380.00",
        "shareholder_funds": "1.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-October2017.zip"
      },
      {
        "url": "/company/04352134/accounts/2016-01-31",
        "pdf_url": "/company/04352134/accounts/2016-01-31.pdf",
        "made_up_date": "2016-01-31",
        "period_start": "2016-01-31",
        "period_end": "2016-01-31",
        "entity_name": "Jules Pharma Limited",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "330.00",
        "debtors": null,
        "cash_bank_in_hand": "18224.00",
        "current_assets": "18224.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": "20797.00",
        "net_current_assets_liabilities": "18224.00",
        "total_assets_less_current_liabilities": "18554.00",
        "net_assets_liabilities": "-2243.00",
        "called_up_share_capital": "1.00",
        "profit_loss_account_reserve": "-2244.00",
        "shareholder_funds": "-2243.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-October2016.zip"
      },
      {
        "url": "/company/04352134/accounts/2015-01-31",
        "pdf_url": "/company/04352134/accounts/2015-01-31.pdf",
        "made_up_date": "2015-01-31",
        "period_start": "2015-01-31",
        "period_end": "2015-01-31",
        "entity_name": "Jules Pharma Limited",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "441.00",
        "debtors": "2256.00",
        "cash_bank_in_hand": "9275.00",
        "current_assets": "11531.00",
        "creditors_due_within_one_year": "2459.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "9072.00",
        "total_assets_less_current_liabilities": "9513.00",
        "net_assets_liabilities": "9513.00",
        "called_up_share_capital": "1.00",
        "profit_loss_account_reserve": "9512.00",
        "shareholder_funds": "9513.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-October2015.zip"
      },
      {
        "url": "/company/04352134/accounts/2014-01-31",
        "pdf_url": "/company/04352134/accounts/2014-01-31.pdf",
        "made_up_date": "2014-01-31",
        "period_start": "2014-01-31",
        "period_end": "2014-01-31",
        "entity_name": "Jules Pharma Limited",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "588.00",
        "debtors": "4694.00",
        "cash_bank_in_hand": "31645.00",
        "current_assets": "36339.00",
        "creditors_due_within_one_year": "4178.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "32161.00",
        "total_assets_less_current_liabilities": "32749.00",
        "net_assets_liabilities": "32749.00",
        "called_up_share_capital": "1.00",
        "profit_loss_account_reserve": "32748.00",
        "shareholder_funds": "32749.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-October2014.zip"
      },
      {
        "url": "/company/04352134/accounts/2013-01-31",
        "pdf_url": "/company/04352134/accounts/2013-01-31.pdf",
        "made_up_date": "2013-01-31",
        "period_start": "2013-01-31",
        "period_end": "2013-01-31",
        "entity_name": "Jules Pharma Limited",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "783.00",
        "debtors": "1620.00",
        "cash_bank_in_hand": "37917.00",
        "current_assets": "39537.00",
        "creditors_due_within_one_year": "8765.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "30772.00",
        "total_assets_less_current_liabilities": "31555.00",
        "net_assets_liabilities": "31555.00",
        "called_up_share_capital": "1.00",
        "profit_loss_account_reserve": "31554.00",
        "shareholder_funds": "31555.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-September2013.zip"
      },
      {
        "url": "/company/04352134/accounts/2012-01-31",
        "pdf_url": "/company/04352134/accounts/2012-01-31.pdf",
        "made_up_date": "2012-01-31",
        "period_start": "2012-01-31",
        "period_end": "2012-01-31",
        "entity_name": "Jules Pharma Limited",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "1045.00",
        "debtors": null,
        "cash_bank_in_hand": "13345.00",
        "current_assets": "13345.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "4389.00",
        "total_assets_less_current_liabilities": "5434.00",
        "net_assets_liabilities": "5434.00",
        "called_up_share_capital": "1.00",
        "profit_loss_account_reserve": "5433.00",
        "shareholder_funds": "5434.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "xml",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-October2012.zip"
      },
      {
        "url": "/company/04352134/accounts/2011-01-31",
        "pdf_url": "/company/04352134/accounts/2011-01-31.pdf",
        "made_up_date": "2011-01-31",
        "period_start": "2011-01-31",
        "period_end": "2011-01-31",
        "entity_name": "Jules Pharma Limited",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "328.00",
        "debtors": null,
        "cash_bank_in_hand": "1156.00",
        "current_assets": "2962.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-9148.00",
        "total_assets_less_current_liabilities": "-8820.00",
        "net_assets_liabilities": "-8820.00",
        "called_up_share_capital": "1.00",
        "profit_loss_account_reserve": "-8821.00",
        "shareholder_funds": "-8820.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "xml",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-October2011.zip"
      },
      {
        "url": "/company/04352134/accounts/2010-01-31",
        "pdf_url": "/company/04352134/accounts/2010-01-31.pdf",
        "made_up_date": "2010-01-31",
        "period_start": "2010-01-31",
        "period_end": "2010-01-31",
        "entity_name": "Jules Pharma Limited",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "694.00",
        "debtors": null,
        "cash_bank_in_hand": "2209.00",
        "current_assets": "2209.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-10387.00",
        "total_assets_less_current_liabilities": "-9693.00",
        "net_assets_liabilities": "-9693.00",
        "called_up_share_capital": "1.00",
        "profit_loss_account_reserve": "-9694.00",
        "shareholder_funds": "-9693.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "xml",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-November2010.zip"
      }
    ],
    "pdf_only_filings": [
      {
        "made_up_date": "2009-01-31",
        "filing_date": "2009-12-04",
        "form_type": "AA",
        "description": "accounts-with-accounts-type-total-exemption-full",
        "paper_filed": true,
        "pdf_url": "/company/04352134/accounts/2009-01-31.pdf",
        "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/04352134/filing-history/MzAwNDI5NDc5OGFkaXF6a2N4/document?format=pdf&download=0"
      },
      {
        "made_up_date": "2008-01-31",
        "filing_date": "2008-10-08",
        "form_type": "AA",
        "description": "accounts-with-accounts-type-total-exemption-full",
        "paper_filed": true,
        "pdf_url": "/company/04352134/accounts/2008-01-31.pdf",
        "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/04352134/filing-history/MjAxNTEwOTY4MmFkaXF6a2N4/document?format=pdf&download=0"
      },
      {
        "made_up_date": "2007-01-31",
        "filing_date": "2007-11-20",
        "form_type": "AA",
        "description": "accounts-with-accounts-type-total-exemption-full",
        "paper_filed": true,
        "pdf_url": "/company/04352134/accounts/2007-01-31.pdf",
        "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/04352134/filing-history/MTg4NjE1OTU1YWRpcXprY3g/document?format=pdf&download=0"
      },
      {
        "made_up_date": "2006-01-31",
        "filing_date": "2006-11-22",
        "form_type": "AA",
        "description": "accounts-with-accounts-type-total-exemption-small",
        "paper_filed": true,
        "pdf_url": "/company/04352134/accounts/2006-01-31.pdf",
        "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/04352134/filing-history/MTcwNzQ4MzczYWRpcXprY3g/document?format=pdf&download=0"
      },
      {
        "made_up_date": "2005-01-31",
        "filing_date": "2005-12-05",
        "form_type": "AA",
        "description": "accounts-with-accounts-type-total-exemption-full",
        "paper_filed": true,
        "pdf_url": "/company/04352134/accounts/2005-01-31.pdf",
        "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/04352134/filing-history/MjgwNDM5MDhhZGlxemtjeA/document?format=pdf&download=0"
      },
      {
        "made_up_date": "2004-01-31",
        "filing_date": "2004-11-30",
        "form_type": "AA",
        "description": "accounts-with-accounts-type-total-exemption-full",
        "paper_filed": true,
        "pdf_url": "/company/04352134/accounts/2004-01-31.pdf",
        "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/04352134/filing-history/ODU4MjIzNjJhZGlxemtjeA/document?format=pdf&download=0"
      },
      {
        "made_up_date": "2003-01-31",
        "filing_date": "2003-11-06",
        "form_type": "AA",
        "description": "accounts-with-accounts-type-medium",
        "paper_filed": true,
        "pdf_url": "/company/04352134/accounts/2003-01-31.pdf",
        "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/04352134/filing-history/MjY4Nzk1MzhhZGlxemtjeA/document?format=pdf&download=0"
      }
    ],
    "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/04352134/filing-history"
  },
  "confirmation_statement": {
    "next_due": "2027-01-24",
    "last_made_up": "2026-01-10"
  },
  "officers": [],
  "psc": [
    {
      "name": "Mr Andrew Nwachukwu Aghadiuno",
      "kind": "individual-person-with-significant-control",
      "person_url": "/person/377132",
      "controlling_company_url": null,
      "natures_of_control": [
        "ownership-of-shares-75-to-100-percent"
      ],
      "notified_on": "2016-04-16",
      "ceased_on": null,
      "nationality": "British",
      "country_of_residence": "England",
      "source": "snapshot"
    }
  ],
  "external_links": [],
  "provenance": {
    "source": "snapshot",
    "first_seen_at": "2026-07-05T12:35:35.811816+00:00",
    "last_seen_snapshot": "2026-08-01",
    "retrieved_at": "2026-08-14T22:38:17.859935+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House."
}